Total de visites
Visites | |
---|---|
CEMCAT ... | 240 |
Total de visites per mes
de setembre 2023 | d’octubre 2023 | de novembre 2023 | de desembre 2023 | de gener 2024 | de febrer 2024 | de març 2024 | |
---|---|---|---|---|---|---|---|
CEMCAT ... | 3 | 4 | 6 | 4 | 9 | 8 | 5 |
Visites per país
Visites | |
---|---|
Espanya | 114 |
Estats Units | 39 |
Irlanda | 11 |
Suècia | 10 |
Xina | 8 |
Costa d'Ivori | 5 |
Corea del Sud | 4 |
França | 3 |
Regne Unit | 3 |
Japó | 3 |
Visites per ciutat
Visites | |
---|---|
Barcelona | 58 |
Chandler | 12 |
Dublin | 11 |
Capellades | 10 |
Sant Feliu de Llobregat | 5 |
Ashburn | 4 |
Busan | 4 |
Daloa | 4 |
Badalona | 3 |
Boardman | 3 |
Documents més visitats
Visites | |
---|---|
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results | 476 |
Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care | 289 |
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome | 281 |
Adherence and satisfaction of smartphone- and smartwatch-based remote active testing and passive monitoring in people with multiple sclerosis: nonrandomized interventional feasibility study | 243 |
Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis: a longitudinal OCT study | 218 |
Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions | 105 |
The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction | 99 |
Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure | 96 |
Immunosenescence in multiple sclerosis: the identification of new therapeutic targets | 88 |
Deciphering Multiple Sclerosis Progression | 87 |